Can We Trust the FDA? Marty Makary on Science, Power & Patients

Healthcare
United States
Started January 16, 2026

(0:00) Friedberg intros FDA Commissioner Marty Makary (3:21) Inside the 42 major FDA reforms in 10 months (7:51) The China Race: Winning back biotech leadership (13:14) Accelerating drug approvals safely, how to cut down on clinical trial timelines (33:13) Reshaping the failed Food Pyramid (41:29) GLP-1s and America's Obesity Epidemic (49:54) Rethinking vaccines from first principles (59:40) Lowering drug prices, the power of AI for healthcare (1:18:57) What causes autism? Follow Marty Makary...

🗳️ Be one of the first to share your view
5 statements to vote on • Your perspective matters
📊 Progress to Consensus Analysis Need: 7+ statements, 50+ votes
Statements 5/7
Total Votes 0/50
💡 Keep voting and adding statements to unlock consensus insights

You're voting anonymously

Your votes are stored locally in your browser. Create an account to have your votes included in consensus analysis.

CLAIM Posted by will Jan 16, 2026
The debate over the FDA's role in drug approval highlights the need for a balanced approach that prioritizes both innovation and patient safety.
0 total votes
CLAIM Posted by will Jan 16, 2026
The FDA's recent reforms demonstrate a commitment to faster drug approvals, which can significantly benefit patients in need of timely treatments.
0 total votes
CLAIM Posted by will Jan 16, 2026
Accelerating drug approvals may compromise safety standards, leading to potential risks for patients that outweigh the benefits of faster access.
0 total votes
CLAIM Posted by will Jan 16, 2026
While AI has potential in healthcare, its application in lowering drug prices must be approached cautiously to avoid unintended consequences.
0 total votes
CLAIM Posted by will Jan 16, 2026
Rethinking the Food Pyramid is crucial to combat America's obesity epidemic, as outdated guidelines fail to address current dietary challenges.
0 total votes

💡 How This Works

  • Add Statements: Post claims or questions (10-500 characters)
  • Vote: Agree, Disagree, or Unsure on each statement
  • Respond: Add detailed pro/con responses with evidence
  • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement